Clinical Trials in Houston

Showing 7961-7980 of 17,885 trials

A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa

NCT02494570

A phase 2 multi-center investigation of efficacy of nab-sirolimus (formerly known as ABI-009 or nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumor (PEComa).

Malignant PEComa

Aadi Bioscience, Inc.34 participantsStarted Oct 2015

Palo Alto, California, United States • Santa Monica, California, United States • Boston, Massachusetts, United States +6 more locations

UNKNOWNNA< 1 mile

CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization

NCT03990623

This trial studies the use of computed tomography (CT) perfusion scans in detecting changes in blood flow to the liver after portal vein embolization in patients with liver cancer. CT perfusion scans use a standard contrast drug given by vein to measure blood flow to the liver. CT perfusion scans may predict the rate and amount of growth of new, healthy tissue on one side of the liver after a portal vein embolization and detect change to the size of the liver tumor as result of the procedure.

Liver and Intrahepatic Bile Duct Carcinoma

M.D. Anderson Cancer Center22 participantsStarted Jul 2018

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

NCT03512262

A 12-month study to measure the efficacy and safety of abaloparatide in men with osteoporosis.

OsteoporosisOsteoporosis, Age-RelatedOsteoporosis Localized to Spine+3 more

Radius Health, Inc.228 participantsStarted May 2018

Birmingham, Alabama, United States • Greenbrae, California, United States • Simi Valley, California, United States +31 more locations

A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa

CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

Find Trials by Condition in Houston

Topical NVN1000 for the Treatment of External Genital and Perianal Warts

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

Effect of Systemic Inflammation on Emotion and Cognition in Patients With Mood Disorder - A Vaccine Study

Use of Wearable Digital Sensors After mRNA Vaccination in Adults

Study of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors

HR-EGG in Medically Refractory Gastroparesis

A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia

Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)

Tavilermide Ophthalmic Solution for the Treatment of Dry Eye

An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine.